Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquilin 4 pseudogene 1 (UBQLN4P1, also known as C3orf12) is classified as a pseudogene in the human genome[3][4][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional; they do not encode functional proteins or have characterized biological functions, and are not considered valid therapeutic or molecular targets. UBQLN4P1 is distinct from the protein-coding gene Ubiquilin 4 (UBQLN4), which is involved in proteasomal degradation and DNA repair, but UBQLN4P1 itself has no established protein-coding potential or molecular function[4]. No disease associations, interacting drugs, or biomarker roles are known for this pseudogene[4][5].\n\nNote: This entry is a pseudogene and should not be considered a drug target or molecular target for therapeutic intervention[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquilin 4 pseudogene 1 (UBQLN4P1).